(Q53122745)

English

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

atrial fibrillation

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Justin Ezekowitz

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

object named as

Elaine M Hylek

16

0 references

object named as

Cetin Erol

10

0 references

Christopher B. Granger

13

object named as

Christopher B Granger

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

3

object named as

Lars Wallentin

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

Bernard J Gersh

12

object named as

Bernard J Gersh

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Renato Delascio Lopes

1

object named as

Renato D Lopes

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

John H. Alexander

20

object named as

John H Alexander

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Raffaele De Caterina

7

object named as

Raffaele De Caterina

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Stefan H Hohnloser

14

object named as

Stefan H Hohnloser

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

17

object named as

John J V McMurray

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Sana M Al-Khatib

2

object named as

Sana M Al-Khatib

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

5

object named as

Jack Ansell

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

J Donald Easton

9

object named as

J Donald Easton

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

John D. Horowitz

15

object named as

John Horowitz

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

4

object named as

Hongqiu Yang

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

18

object named as

Puneet Mohan

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

8

object named as

Paul Dorian

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

author name string

M Cecilia Bahit

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Dragos Vinereanu

19

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

language of work or name

0 references

publication date

2 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

380

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

9855

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

1749-1758

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving stroke risk stratification in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke risk in atrial fibrillation patients on warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the P

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of care for atrial fibrillation among patients hospitalized for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960986-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)60986-6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

release_szimqbanbvewvnau73uaqdnqxi

1 reference

https://api.fatcat.wiki/v0/release/szimqbanbvewvnau73uaqdnqxi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23036896

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53122745&oldid=2032991443"